X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs IPCA LABS - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA IPCA LABS ABBOTT INDIA/
IPCA LABS
 
P/E (TTM) x 32.8 27.7 118.7% View Chart
P/BV x 8.2 2.1 386.6% View Chart
Dividend Yield % 0.8 0.2 337.9%  

Financials

 ABBOTT INDIA   IPCA LABS
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
IPCA LABS
Mar-17
ABBOTT INDIA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs6,015643 935.5%   
Low Rs3,707503 737.3%   
Sales per share (Unadj.) Rs1,236.9254.4 486.2%  
Earnings per share (Unadj.) Rs122.216.1 760.3%  
Cash flow per share (Unadj.) Rs129.029.8 433.2%  
Dividends per share (Unadj.) Rs35.001.00 3,500.0%  
Dividend yield (eoy) %0.70.2 412.5%  
Book value per share (Unadj.) Rs521.2194.6 267.9%  
Shares outstanding (eoy) m21.25126.20 16.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.92.3 174.5%   
Avg P/E ratio x39.835.7 111.6%  
P/CF ratio (eoy) x37.719.2 195.9%  
Price / Book Value ratio x9.32.9 316.7%  
Dividend payout %28.66.2 460.3%   
Avg Mkt Cap Rs m103,29672,300 142.9%   
No. of employees `0003.013.3 22.2%   
Total wages/salary Rs m3,3706,960 48.4%   
Avg. sales/employee Rs Th8,891.82,413.5 368.4%   
Avg. wages/employee Rs Th1,140.0523.2 217.9%   
Avg. net profit/employee Rs Th878.3152.4 576.1%   
INCOME DATA
Net Sales Rs m26,28432,106 81.9%  
Other income Rs m504226 223.5%   
Total revenues Rs m26,78932,332 82.9%   
Gross profit Rs m3,6654,448 82.4%  
Depreciation Rs m1441,730 8.3%   
Interest Rs m8241 3.4%   
Profit before tax Rs m4,0172,703 148.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,421675 210.5%   
Profit after tax Rs m2,5962,028 128.0%  
Gross profit margin %13.913.9 100.7%  
Effective tax rate %35.425.0 141.6%   
Net profit margin %9.96.3 156.4%  
BALANCE SHEET DATA
Current assets Rs m14,44617,340 83.3%   
Current liabilities Rs m4,7259,559 49.4%   
Net working cap to sales %37.024.2 152.6%  
Current ratio x3.11.8 168.6%  
Inventory Days Days51100 51.2%  
Debtors Days Days2057 34.4%  
Net fixed assets Rs m1,11320,779 5.4%   
Share capital Rs m213252 84.2%   
"Free" reserves Rs m10,80824,499 44.1%   
Net worth Rs m11,07624,553 45.1%   
Long term debt Rs m03,517 0.0%   
Total assets Rs m16,24139,595 41.0%  
Interest coverage x497.012.2 4,064.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.60.8 199.6%   
Return on assets %16.05.7 279.9%  
Return on equity %23.48.3 283.8%  
Return on capital %36.310.5 346.5%  
Exports to sales %0.648.6 1.3%   
Imports to sales %12.614.2 88.8%   
Exports (fob) Rs m16215,617 1.0%   
Imports (cif) Rs m3,3224,571 72.7%   
Fx inflow Rs m26815,617 1.7%   
Fx outflow Rs m3,9275,828 67.4%   
Net fx Rs m-3,6599,790 -37.4%   
CASH FLOW
From Operations Rs m2,5142,764 91.0%  
From Investments Rs m-800-1,432 55.8%  
From Financial Activity Rs m-803-1,591 50.5%  
Net Cashflow Rs m912-259 -352.4%  

Share Holding

Indian Promoters % 0.0 45.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 11.4 69.3%  
FIIs % 0.1 25.3 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 17.4 98.3%  
Shareholders   18,270 36,892 49.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   J.B.CHEMICALS  SUVEN LIFE  CIPLA  CADILA HEALTHCARE  ALEMBIC LTD  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 18, 2017 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - FULFORD INDIA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS